Table 1.
Group A (n=56) | Group B (n=47) | p | |
---|---|---|---|
Age (years) MV±SD | 62±7 | 59±9 | 0.134 |
Male gender N (%) | 49(88) | 41(87) | 0.968 |
Smoking history N (%) | 50(89) | 44 (94) | 0.438 |
Co-morbidities N (%) | 50(89) | 34(72) | 0.027 |
Hypertension N (%) | 28(50) | 18(38) | 0.234 |
Coronary disease N (%) | 11(20) | 9(19) | 0.950 |
Heart failure N (%) | 4(7) | 1(2) | 0.238 |
Diabetes mellitus N (%) | 7(13) | 4(8) | 0.514 |
Chronic renal failure N (%) | 0(0) | 2(4) | 0.119 |
COPD stage: I/II/III/IV N (%) | 10(18)/ 39(69)/ 6(11)/ 1(2) | 24(51)/ 22(47)/ 1(2)/ 0(0) | 0.002 |
Basal spirometry: | |||
FEV1 (mL) MV±SD | 1948±569 | 2509±741 | <0.001 |
FEV1% pred. MV±SD | 65±14 | 79±18 | <0.001 |
VC (mL) MV±SD | 3352±873 | 3731±1088 | 0.055 |
VC% pred. MV±SD | 88±15 | 94±21 | 0.116 |
Tiffneau index % MV±SD | 56±8 | 62±6 | <0.001 |
FEF50% MV±SD | 29±14 | 44±24 | <0.001 |
IC% MV±SD | 74±11 | 84±12 | <0.01 |
FEF25% MV±SD | 27±18 | 42±24 | 0.001 |
Pulmonary resection: | |||
Pneumonectomy N (%) | 13(23) | 5(11) | 0.094 |
Lobectomy N (%) | 43(77) | 42(89) | 0.094 |
Total hospital stay (days) MV±SD | 36±19 | 25±12 | <0.001 |
Preop.hospital stay (days) MV±SD | 21±12 | 9±6 | <0.001 |
Postop.hospital stay (days) MV±SD | 16±9 | 16±8 | 0.571 |
Total complications N (%) | 20(36) | 21(45) | 0.354 |
Pulmonary complications N (%) | 17(30) | 20(43) | 0.199 |
In-hospital mortality N (%) | 2(4) | 0(0) | 0.191 |
COPD = chronic obstructive pulmonary disease.